Do symptoms moderate the association between participation and executive functions outcomes among people with schizophrenia?

Kaizerman-Dinerman, Alona; Roe, David; Demeter, Naor; Josman, Naomi

Kaizerman-Dinerman, Alona; Roe, David; Demeter, Naor; Josman, Naomi.

Afiliação

Kaizerman-Dinerman A; Department of Occupational Therapy, Faculty of Social Welfare & Health Sciences, University of Haifa, Haifa, Israel.
Roe D; Department of Community Mental Health, Faculty of Social Welfare & Health Sciences, University of Haifa, Haifa, Israel.
Demeter N; Department of Occupational Therapy, Faculty of Social Welfare & Health Sciences, University of Haifa, Haifa, Israel.
Josman N; Department of Occupational Therapy, Faculty of Social Welfare & Health Sciences, University of Haifa, Haifa, Israel. njosman@univ.haifa.ac.il.

BMC Psychiatry ; 23(1): 42, 2023 01 17.

Article em En | MEDLINE | ID: mdl-36650458

Assuntos

Antipsicóticos; Metacognição; Esquizofrenia; Humanos; Antipsicóticos/uso terapêutico; Função Executiva; Esquizofrenia/tratamento farmacológico; Resultado do Tratamento

Palavras-chave

Metacognitive limitation; Moderator; PANSS; Participation; Positive and negative syndrome scale; Symptom

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Metacognição Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Psychiatry Assunto da revista: PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google